亞諾法生技股份有限公司

  • 公司英文名稱:Abnova(Taiwan)Corporation
  • 公司網址:http://www.abnova.com
  • 股票代號:4133
  • 成立時間:2002-01-04
  • 發展階段:上市
  • 公司地區:台北市內湖區洲子街108號9樓
  • 資本額:6.06億
  • 董事長:黃韋伯
  • 總經理:黃韋伯

產業領域

A05生物製劑(生物藥、抗體、蛋白質、疫苗)、B04體外診斷用醫材(IVD)與服務

公司簡介

Abnova is the world's largest antibody manufacturer. We have the capacity of generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month. Rather than the traditional method of antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to have at least one antibody to every human expressed gene in human genome. We manufacture all our products, recombinant proteins and antibodies in our state-of-the-art production and SPF animal facilities. We also have multiple clones for the monoclonal antibody, and their access is available to partners and collaborators from the academic institutions and industry.

應用市場

單株抗體、多株抗體、蛋白質、檢驗試劑、循環稀有細胞富集檢測系統之研發、生產、銷售

相關文章